獸醫CRO市場-全球產業規模、佔有率、趨勢、機會和預測，按服務類型、動物類型、應用、地區和競爭細分2019-2029F

2023 年全球獸醫CRO 市場估值為10.2 億美元，預計在預測期內將強勁成長，到2029 年複合年成長率為8.23%。正在經歷顯著成長。獸藥CRO 透過從臨床前研究到臨床試驗的專業服務，在支持獸藥、生物製品和醫療器材的發展方面發揮關鍵作用。不斷成長。隨著寵物數量的激增和畜牧業的強化，對治療癌症、傳染病和動物慢性病等疾病的創新療法的需求不斷增加。獸醫CRO 提供進行臨床前研究的專業知識，以評估新藥和療法的安全性和有效性，從而促進突破性獸藥的開發。藥物的重要性的認知。寵物主人和畜牧生產者擴大投資於先進的獸醫治療和預防保健措施，推動了對專業獸醫CRO 服務的需求。獸醫領域的擴張。獸醫 CRO 提供全面的監管支援服務，幫助客戶應對複雜的監管環境，並簡化各個地區獸醫產品的核准流程。臨床前和臨床研究。獸醫 CRO 利用從分子診斷到影像技術的最先進的工具和平台，提供準確可靠的結果，進一步推動市場成長。需求、對動物疾病新療法的追求以及研究技術的進步。隨著全球對動物健康重要性的日益認知，獸醫 CRO 預計將在推動獸醫醫學和提高動物福祉方面發揮關鍵作用。

主要市場促進因素

動物疾病盛行率增加

寵物擁有量的成長

獸藥產業全球化

主要市場挑戰

監理複雜性

人才獲取和保留

主要市場趨勢

更加關注伴侶動物健康

研究與開發活動外包

細分市場洞察

服務類型洞察

動物類型見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型（臨床試驗、毒理學、市場授權監管支援等）
  • 依動物類型（狗、貓等）
  • 依應用（腫瘤、傳染病、心血管疾病、代謝疾病、其他）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按地區

第 6 章：亞太地區獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 7 章：歐洲獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 8 章：北美獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 9 章：南美洲獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲獸醫 CRO 市場展望

• 市場規模預測
  • 按價值
• 市佔率預測
  • 按服務類型
  • 依動物類型
  • 按申請
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 埃及

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢發展

• 最近的發展
• 產品發布
• 併購

第 13 章：全球獸醫 CRO 市場：SWOT 分析

第 14 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• Charles River Laboratories, Inc.
• Clinvet International Pty Ltd.
• Klifovet AG
• Lohlein Wolf Vet Research LLC
• Oncovet Clinical Research
• ONDAX Incorporation
• Triveritas Group LLC.
• Veterinary Research Management (VRM) Ltd
• Vet Pharm, Inc.
• Vetspen Srl

第 16 章：策略建議

第 17 章：關於我們免責聲明

Global Veterinary CRO Market was valued at USD 1.02 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.23%through 2029.The Global Veterinary Contract Research Organization (CRO) market is undergoing significant growth, fueled by various factors including the rising prevalence of animal diseases, increased pet ownership, and a growing demand for animal healthcare services. Veterinary CROs are pivotal in supporting the development of veterinary pharmaceuticals, biologics, and medical devices through specialized services spanning from preclinical research to clinical trials.The primary drivers propelling growth in the veterinary CRO market include the escalating need for effective treatments for diverse animal diseases. With the surge in pet ownership and intensified livestock farming practices, there's an increasing demand for innovative therapies addressing conditions like cancer, infectious diseases, and chronic ailments in animals. Veterinary CROs provide expertise in conducting preclinical studies to assess the safety and efficacy of new drugs and therapies, thus facilitating the development of groundbreaking veterinary medicines.The growing emphasis on animal welfare and the human-animal bond has heightened awareness regarding the significance of delivering high-quality healthcare services to animals. Pet owners and livestock producers are increasingly investing in advanced veterinary treatments and preventive care measures, driving the demand for specialized veterinary CRO services.Furthermore, the globalization of the veterinary pharmaceutical industry and expanding regulatory requirements for product approval have contributed to the expansion of the veterinary CRO market. Veterinary CROs offer comprehensive regulatory support services, aiding clients in navigating intricate regulatory landscapes and streamlining the approval process for veterinary products across various regions.Advancements in technology and the emergence of innovative research methodologies are enhancing the capabilities of veterinary CROs to conduct efficient and cost-effective preclinical and clinical studies. Leveraging state-of-the-art tools and platforms, from molecular diagnostics to imaging techniques, veterinary CROs deliver accurate and reliable results, further propelling market growth.In conclusion, the Global Veterinary CRO market is experiencing robust expansion driven by factors such as the growing demand for animal healthcare services, the quest for novel treatments for animal diseases, and advancements in research technologies. With the increasing global recognition of the importance of animal health, veterinary CROs are poised to play a pivotal role in advancing veterinary medicine and enhancing the well-being of animals.

Key Market Drivers

Increasing Prevalence of Animal Diseases

The increasing prevalence of animal diseases is a significant factor driving growth in the Global Veterinary Contract Research Organization (CRO) market. Various factors contribute to this trend, including environmental changes, intensification of livestock farming practices, and globalization of trade. As a result, there has been a heightened demand for effective veterinary treatments and preventive measures, leading to increased collaboration between pharmaceutical companies, researchers, and veterinary CROs. The primary drivers of the rising prevalence of animal diseases is environmental changes, including climate change and habitat destruction. These changes can alter ecosystems, leading to the emergence and spread of new pathogens and the expansion of disease vectors. The environmental stressors such as pollution and deforestation can weaken animals' immune systems, making them more susceptible to infections and diseases. The intensification of livestock farming practices has contributed to the spread of infectious diseases among animals. Dense animal populations, inadequate sanitation, and poor biosecurity measures create favorable conditions for disease transmission and outbreaks. Livestock diseases not only pose risks to animal health and welfare but also have significant economic implications for farmers and the agricultural industry. The globalization of trade has facilitated the rapid spread of animal diseases across borders. The movement of animals, animal products, and vectors can lead to the introduction of pathogens into new regions, increasing the risk of disease outbreaks and transmission. This interconnectedness underscores the importance of international collaboration and coordinated efforts in disease surveillance, prevention, and control. In response to the growing challenges posed by animal diseases, pharmaceutical companies and researchers are increasingly turning to veterinary CROs for support. Veterinary CROs offer specialized services in preclinical research, clinical trials, and regulatory affairs, helping to accelerate the development and approval of new veterinary drugs, vaccines, and therapies. By leveraging their expertise and infrastructure, veterinary CROs play a vital role in advancing veterinary medicine and addressing the healthcare needs of animals worldwide. The increasing prevalence of animal diseases presents significant opportunities for the Global Veterinary CRO market. As the demand for effective veterinary treatments continues to rise, veterinary CROs are well-positioned to support research and development efforts aimed at improving animal health and welfare.

Growth in Pet Ownership

The growth in pet ownership is a significant driver of the Global Veterinary Contract Research Organization (CRO) market, as it creates a higher demand for veterinary healthcare services and products. Pet ownership has been on the rise globally due to various factors, including urbanization, changing lifestyles, and increased awareness of the benefits of companion animals for mental and physical well-being. As more people welcome pets into their homes, the need for quality veterinary care becomes increasingly important, leading to expanded opportunities for veterinary CROs. The key reasons behind the growth in pet ownership is urbanization. As more people move to urban areas, there is a growing trend of individuals adopting pets as companions. Pets provide emotional support, companionship, and stress relief, making them valued members of urban households. The increasing number of pet-friendly housing options and amenities in cities further encourages pet ownership among urban dwellers. Changing lifestyles also play a significant role in the growth of pet ownership. With hectic work schedules and busy lifestyles, many people find solace and joy in the companionship of pets. Pets offer unconditional love, companionship, and entertainment, making them indispensable parts of many families. The growing emphasis on work-life balance and self-care has led more individuals to seek the companionship of pets as a way to reduce stress and improve overall well-being. The increased awareness of the health benefits associated with pet ownership has contributed to the growth in pet ownership. Studies have shown that owning pets can have positive effects on mental and physical health, including reduced stress, lower blood pressure, and increased physical activity. As a result, more people are choosing to adopt pets as part of their efforts to lead healthier and happier lives. The growth in pet ownership presents significant opportunities for the Global Veterinary CRO market. With more pet owners seeking high-quality healthcare services and products for their beloved companions, there is a growing demand for veterinary CROs to support research and development efforts in the pet healthcare sector. Veterinary CROs play a vital role in advancing veterinary medicine by providing specialized services in preclinical research, clinical trials, and regulatory affairs, ultimately contributing to the health and well-being of companion animals worldwide.

Globalization of Veterinary Pharmaceutical Industry

The globalization of the veterinary pharmaceutical industry is a key driver of the Global Veterinary Contract Research Organization (CRO) market, as it creates a growing need for specialized research and development services to support the development of veterinary drugs, vaccines, and medical devices. The veterinary pharmaceutical industry has witnessed significant globalization in recent years, driven by factors such as increasing demand for animal healthcare products, expansion of multinational companies, and harmonization of regulatory standards across regions. The primary drivers of the globalization of the veterinary pharmaceutical industry is the rising demand for animal healthcare products worldwide. As pet ownership and livestock production continue to increase globally, there is a growing need for effective veterinary treatments and preventive measures to address a wide range of animal diseases and health conditions. This growing demand has prompted pharmaceutical companies to expand their presence in new markets and regions, driving the globalization of the veterinary pharmaceutical industry. The expansion of multinational pharmaceutical companies has facilitated the globalization of the veterinary pharmaceutical industry. These companies operate across multiple regions and markets, leveraging their global presence to develop and distribute veterinary products worldwide. With operations spanning different countries and regulatory jurisdictions, multinational companies require specialized support in research and development, regulatory affairs, and clinical trials to navigate complex regulatory landscapes and ensure compliance with local requirements. The harmonization of regulatory standards and guidelines for veterinary products has accelerated the globalization of the veterinary pharmaceutical industry. Regulatory agencies around the world are increasingly adopting international standards and guidelines for the approval of veterinary drugs and medical devices, facilitating the movement of products across borders. This harmonization creates opportunities for veterinary CROs to provide regulatory support services, such as dossier preparation, regulatory submissions, and compliance assistance, to pharmaceutical companies seeking market authorization for their products in different regions. The globalization of the veterinary pharmaceutical industry presents significant opportunities for the Global Veterinary CRO market. As pharmaceutical companies expand their operations globally and seek market approval for veterinary products in new regions, there is a growing demand for specialized research and development services offered by veterinary CROs. By providing expertise in preclinical research, clinical trials, and regulatory affairs, veterinary CROs play a vital role in supporting the development and commercialization of veterinary drugs, vaccines, and medical devices on a global scale.

Key Market Challenges

Regulatory Complexity

Regulatory complexity poses a significant challenge to the Global Veterinary Contract Research Organization (CRO) market, impacting the development and approval process of veterinary pharmaceuticals, biologics, and medical devices. Veterinary CROs play a crucial role in supporting clients through various stages of regulatory compliance, including preclinical research, clinical trials, and market authorization. However, navigating the complex regulatory landscapes across different regions and countries requires specialized expertise and resources. The primary challenges faced by veterinary CROs is the variability and inconsistency in regulatory requirements across different jurisdictions. Regulatory standards, guidelines, and approval processes can vary significantly between countries and regions, leading to challenges in harmonizing regulatory strategies and submissions for veterinary products intended for global markets. This variability necessitates careful planning and coordination to ensure compliance with local regulatory requirements while maintaining efficiency and cost-effectiveness. The regulatory agencies often update and revise their guidelines and requirements, adding further complexity to the regulatory landscape. Keeping abreast of these changes and ensuring timely compliance can be challenging for veterinary CROs, particularly those operating in multiple regions simultaneously. Failure to stay updated on regulatory developments can result in delays in research projects, increased costs, and potential regulatory hurdles during the approval process. The regulatory approval process for veterinary products can be lengthy and time-consuming, requiring extensive documentation, data submission, and review by regulatory authorities. Delays in regulatory approvals can have significant implications for clients, including delayed product launches, loss of market opportunities, and increased development costs. Veterinary CROs must effectively manage timelines, anticipate regulatory challenges, and provide strategic guidance to clients to mitigate risks and expedite the approval process. In response to these challenges, veterinary CROs must invest in regulatory expertise, stay informed about evolving regulatory requirements, and establish robust regulatory compliance strategies. Collaboration with regulatory consultants, engagement with regulatory agencies, and participation in industry forums can also help veterinary CROs navigate regulatory complexities and ensure successful outcomes for their clients in the global veterinary pharmaceutical market.

Talent Acquisition and Retention

Talent acquisition and retention present significant challenges for the Global Veterinary Contract Research Organization (CRO) market, as skilled professionals are essential for delivering high-quality research and development services. Veterinary CROs require a diverse range of expertise, including veterinarians, scientists, research personnel, regulatory affairs specialists, and project managers, to effectively support clients in the development of veterinary pharmaceuticals, biologics, and medical devices. The primary challenges in talent acquisition for veterinary CROs is the shortage of qualified professionals with specialized skills and experience. The veterinary industry is highly competitive, with demand often outstripping supply for skilled professionals, particularly in niche areas such as preclinical research, clinical trials, and regulatory affairs. Identifying and recruiting talented individuals with the right qualifications and expertise can be challenging, requiring extensive networking, outreach, and competitive compensation packages to attract top talent. Once hired, retaining skilled professionals poses its own set of challenges for veterinary CROs. High turnover rates can disrupt research projects, impact productivity, and lead to increased recruitment and training costs. Factors contributing to turnover may include limited career advancement opportunities, lack of professional development programs, and workplace dissatisfaction. Veterinary CROs must prioritize employee engagement, career growth, and work-life balance to foster a supportive and rewarding work environment that promotes employee retention. The global nature of the veterinary CRO market adds complexity to talent acquisition and retention efforts. As veterinary CROs expand their operations into new regions and markets, they must adapt to local labor markets, cultural differences, and regulatory requirements. Recruiting and retaining talent in diverse geographical locations may require tailored strategies and initiatives to address local workforce dynamics and preferences. In response to these challenges, veterinary CROs must prioritize talent management strategies that focus on attracting, developing, and retaining skilled professionals. This includes investing in ongoing training and development programs, offering competitive compensation and benefits packages, fostering a culture of innovation and collaboration, and providing opportunities for career advancement and growth. By investing in their human capital, veterinary CROs can strengthen their capabilities, enhance client satisfaction, and position themselves for long-term success in the global veterinary pharmaceutical market.

Key Market Trends

Increased Focus on Companion Animal Health

The Global Veterinary Contract Research Organization (CRO) market is witnessing an increased focus on companion animal health, reflecting the growing importance of pets in households worldwide. This trend is driven by several factors, including rising pet ownership rates, increased spending on pet healthcare, and a growing awareness of the role pets play in human well-being. As a result, veterinary CROs are experiencing heightened demand for research and development services tailored to the needs of companion animals, such as dogs, cats, and horses. The primary drivers of the increased focus on companion animal health is the rising number of pet owners globally. Pets are increasingly viewed as valued members of the family, with owners willing to invest in their health and well-being. This shift in perception has led to increased spending on pet healthcare products and services, including veterinary pharmaceuticals, biologics, and medical devices, driving demand for research and development support from veterinary CROs. Advancements in veterinary medicine and technology have expanded the range of treatment options available for companion animals, leading to increased research and development activities in this sector. Veterinary CROs play a crucial role in supporting the development and commercialization of new and innovative therapies for companion animals, leveraging their expertise in preclinical research, clinical trials, and regulatory affairs. The human-animal bond has gained recognition as an important aspect of human well-being, with pets providing emotional support, companionship, and social connection to their owners. This heightened awareness of the benefits of pet ownership has further fueled demand for high-quality healthcare services for companion animals, driving growth in the veterinary CRO market. In response to the increased focus on companion animal health, veterinary CROs are expanding their capabilities and service offerings to meet the evolving needs of clients in this sector. This includes investing in specialized expertise, state-of-the-art facilities, and advanced technologies to support research and development efforts aimed at improving the health and well-being of companion animals worldwide. By capitalizing on the growing opportunities in companion animal health, veterinary CROs can drive innovation and contribute to advancements in veterinary medicine for the benefit of pets and their owners.

Outsourcing of Research and Development Activities

The outsourcing of research and development (RD) activities has become a prevalent trend in the Global Veterinary Contract Research Organization (CRO) market, driven by various factors including cost reduction, access to specialized expertise, and increased flexibility. Pharmaceutical companies, biotechnology firms, and academic institutions are increasingly turning to veterinary CROs to outsource a wide range of RD activities, including preclinical research, clinical trials, regulatory affairs, and product development. The primary drivers of the outsourcing trend is the desire to reduce costs and improve operational efficiency. Veterinary CROs offer cost-effective solutions for conducting RD activities, as they can leverage economies of scale, infrastructure, and resources to deliver high-quality services at competitive prices. Outsourcing allows clients to avoid the substantial upfront investments associated with building and maintaining in-house research facilities and capabilities, making it an attractive option for organizations seeking to optimize their RD budgets. The outsourcing provides access to specialized expertise and capabilities that may not be available in-house. Veterinary CROs employ highly skilled professionals with expertise in veterinary medicine, scientific research, regulatory affairs, and project management, enabling them to provide comprehensive support across all stages of the product development lifecycle. Clients benefit from the collective knowledge, experience, and resources of veterinary CROs, enhancing the quality and efficiency of their RD efforts. The outsourcing RD activities to veterinary CROs offers increased flexibility and scalability, allowing clients to adapt to changing market dynamics and resource requirements. Veterinary CROs can provide tailored solutions to meet the unique needs and objectives of each client, whether it involves conducting a single study or managing entire RD programs. This flexibility enables clients to accelerate timelines, minimize risks, and respond quickly to emerging opportunities in the veterinary pharmaceutical market. The outsourcing of RD activities to veterinary CROs represents a strategic approach for organizations seeking to optimize their resources, access specialized expertise, and accelerate innovation in the Global Veterinary CRO market. By leveraging the capabilities of veterinary CROs, clients can enhance their competitiveness, drive efficiency, and bring innovative veterinary products to market more effectively.

Segmental Insights

Service Type Insights

Based onservice type,clinical trials segment dominated the Global Veterinary CRO Market in 2023.This is ascribed due to their pivotal role in drug development and healthcare advancement. Clinical trials are essential phases in assessing the safety and efficacy of new treatments, medications, or medical devices before they can be approved for widespread use. They involve rigorous testing on human subjects, providing crucial data on the potential benefits and risks of the intervention. Regulatory agencies worldwide require extensive clinical trial data to evaluate and authorize new medical products, making this phase indispensable in the drug development process. The clinical trials drive innovation by fostering collaboration between researchers, clinicians, and pharmaceutical companies. Their significance lies in shaping the future of medicine, offering hope for improved treatments and better patient outcomes. Thus, Clinical Trials emerge as the dominant sector due to their foundational role in advancing healthcare and facilitating regulatory approval processes.

Animal Type Insights

Based on animal type, Dogs segment dominated the Global Veterinary CRO Market in 2023. This is ascribed due to their long-standing history of companionship with humans, their versatility in roles such as working, service, and therapy animals, and their widespread popularity as pets. Dogs have been domesticated for thousands of years and are deeply integrated into human societies across different cultures. They often serve as loyal companions, guardians, and helpers, contributing to their prominence in households worldwide. The diversity of dog breeds offers options to suit various lifestyles and preferences. While cats also hold significant popularity as pets, Dogs' extensive roles in human life and their deep-rooted connection with people often make them the dominant choice among companion animals. Therefore, Dogs emerge as dominant among Dogs, Cats, and Others due to their multifaceted roles and enduring bond with humans.

Regional Insights

North America dominates the Global Veterinary CRO Market primarily due to several key factors. North America boasts a highly developed veterinary pharmaceutical industry with a strong emphasis on research and development. Major pharmaceutical companies and biotechnology firms in the region often seek the services of veterinary CROs for their expertise and infrastructure. North America benefits from a large population of companion animals and livestock, driving demand for veterinary products and services. This high demand fuels the need for extensive research and clinical trials, further boosting the growth of the veterinary CRO market in the region. North America has well-established regulatory frameworks and standards for veterinary products, creating a conducive environment for research and development activities. The presence of leading regulatory agencies such as the FDA in the United States ensures compliance with rigorous regulatory requirements, instilling confidence in the quality and safety of veterinary products developed with the assistance of CROs. These factors contribute to North America's dominance in the Global Veterinary CRO Market.

Key Market Players

Charles River Laboratories, Inc

Clinvet International Pty Ltd.

Klifovet AG

Lohlein Wolf Vet Research LLC

Oncovet Clinical Research

ONDAX Incorporation

Triveritas Group LLC.

Veterinary Research Management (VRM) Ltd

Vet Pharm, Inc.

Vetspen Srl.

Report Scope:

In this report, the Global Veterinary CRO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO Market,By Service Type:

• Clinical Trials
• Toxicology
• Market Authorization Regulatory Support
• Integrated Anesthesia Workstation

Veterinary CRO Market,By Animal Type:

• Dogs
• Cats
• Others

Veterinary CRO Market,By Application:

• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Metabolic Disease
• Others

Veterinary CRO Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Veterinary CRO Market.

Available Customizations:

Global Veterinary CRO Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.Global Veterinary CRO Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1. By Service Type (Clinical Trials, Toxicology, Market Authorization Regulatory Support and Others)
  • 5.2.2. By Animal Type (Dogs, Cats and Others)
  • 5.2.3. By Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Metabolic Disease, Others)
  • 5.2.4. By Region
  • 5.2.5.By Company (2023)
• 5.3.Market Map
  • 5.3.1.By Service Type
  • 5.3.2.By Animal Type
  • 5.3.3.By Application
  • 5.3.4.By Region

6.Asia Pacific Veterinary CRO Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Service Type
  • 6.2.2.By Animal Type
  • 6.2.3.By Application
  • 6.2.4.By Country
• 6.3.Asia Pacific: Country Analysis
  • 6.3.1.China Veterinary CRO Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Service Type
      • 6.3.1.2.2.By Animal Type
      • 6.3.1.2.3.By Application
  • 6.3.2.India Veterinary CRO Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Service Type
      • 6.3.2.2.2.By Animal Type
      • 6.3.2.2.3.By Application
  • 6.3.3.Australia Veterinary CRO Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Service Type
      • 6.3.3.2.2.By Animal Type
      • 6.3.3.2.3.By Application
  • 6.3.4.Japan Veterinary CRO Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Service Type
      • 6.3.4.2.2.By Animal Type
      • 6.3.4.2.3.By Application
  • 6.3.5.South Korea Veterinary CRO Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Service Type
      • 6.3.5.2.2.By Animal Type
      • 6.3.5.2.3.By Application

7.Europe Veterinary CRO Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Service Type
  • 7.2.2.By Animal Type
  • 7.2.3.By Application
  • 7.2.4. By Country
• 7.3.Europe: Country Analysis
  • 7.3.1.France Veterinary CRO Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Service Type
      • 7.3.1.2.2.By Animal Type
      • 7.3.1.2.3.By Application
  • 7.3.2.Germany Veterinary CRO Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Service Type
      • 7.3.2.2.2.By Animal Type
      • 7.3.2.2.3.By Application
  • 7.3.3.Spain Veterinary CRO Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Service Type
      • 7.3.3.2.2.By Animal Type
      • 7.3.3.2.3.By Application
  • 7.3.4.Italy Veterinary CRO Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Service Type
      • 7.3.4.2.2.By Animal Type
      • 7.3.4.2.3.By Application
  • 7.3.5.United Kingdom Veterinary CRO Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Service Type
      • 7.3.5.2.2.By Animal Type
      • 7.3.5.2.3.By Application

8.North America Veterinary CRO Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Service Type
  • 8.2.2.By Animal Type
  • 8.2.3.By Application
  • 8.2.4.By Country
• 8.3.North America: Country Analysis
  • 8.3.1.United States Veterinary CRO Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Service Type
      • 8.3.1.2.2.By Animal Type
      • 8.3.1.2.3.By Application
  • 8.3.2.Mexico Veterinary CRO Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Service Type
      • 8.3.2.2.2.By Animal Type
      • 8.3.2.2.3.By Application
  • 8.3.3.Canada Veterinary CRO Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Service Type
      • 8.3.3.2.2.By Animal Type
      • 8.3.3.2.3.By Application

9.South America Veterinary CRO Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1. By Service Type
  • 9.2.2. By Animal Type
  • 9.2.3. By Application
  • 9.2.4.By Country
• 9.3.South America: Country Analysis
  • 9.3.1.Brazil Veterinary CRO Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Service Type
      • 9.3.1.2.2.By Animal Type
      • 9.3.1.2.3.By Application
  • 9.3.2.Argentina Veterinary CRO Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Service Type
      • 9.3.2.2.2.By Animal Type
      • 9.3.2.2.3.By Application
  • 9.3.3.Colombia Veterinary CRO Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Service Type
      • 9.3.3.2.2.By Animal Type
      • 9.3.3.2.3.By Application

10.Middle East and Africa Veterinary CRO Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value
• 10.2.Market Share Forecast
  • 10.2.1. By Service Type
  • 10.2.2. By Animal Type
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3.MEA: Country Analysis
  • 10.3.1.South Africa Veterinary CRO Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Service Type
      • 10.3.1.2.2.By Animal Type
      • 10.3.1.2.3.By Application
  • 10.3.2.Saudi Arabia Veterinary CRO Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Service Type
      • 10.3.2.2.2.By Animal Type
      • 10.3.2.2.3.By Application
  • 10.3.3.UAE Veterinary CRO Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Service Type
      • 10.3.3.2.2.By Animal Type
      • 10.3.3.2.3.By Application
  • 10.3.4.Egypt Veterinary CRO Market Outlook
    • 10.3.4.1.Market Size Forecast
      • 10.3.4.1.1.By Value
    • 10.3.4.2.Market Share Forecast
      • 10.3.4.2.1.By Service Type
      • 10.3.4.2.2.By Animal Type
      • 10.3.4.2.3.By Application

11.Market Dynamics

• 11.1.Drivers
• 11.2.Challenges

12.Market Trends Developments

• 12.1.Recent Developments
• 12.2.Product Launches
• 12.3.Mergers Acquisitions

13.Global Veterinary CRO Market: SWOT Analysis

14.Porter's Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Product

15.Competitive Landscape

• 15.1.Charles River Laboratories, Inc.
  • 15.1.1.Business Overview
  • 15.1.2.Company Snapshot
  • 15.1.3.Products Services
  • 15.1.4.Financials (In case of listed)
  • 15.1.5.Recent Developments
• 15.2. Clinvet International Pty Ltd.
• 15.3. Klifovet AG
• 15.4. Lohlein Wolf Vet Research LLC
• 15.5. Oncovet Clinical Research
• 15.6. ONDAX Incorporation
• 15.7. Triveritas Group LLC.
• 15.8. Veterinary Research Management (VRM) Ltd
• 15.9. Vet Pharm, Inc.
• 15.10. Vetspen Srl

16.Strategic Recommendations

17. About Us Disclaimer